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LETTER TO THE EDITOR
Should cancer survivors fear radiation-induced sarcomas?
Sir: We read with interest the leading article in
your inaugural Sarcoma issue on the subject of
radiotherapy-induced sarcomas,
1 and congratulate
the author on a meticulous review of the literature.
We do, however, have some additional comments to
make with respect to this important subject.
First, while we would certainly agree that the
absolute incidence of radiotherapy-induced sarco-
mas is lowÐ and that this in itself should not suf® ce
to deter patients from receiving radiotherapy where
indicatedÐ it is clear that sarcomas represent only a
minority of all radiation-induced neoplasms.
2 Ac-
cordingly, readers of the review should not mis-
takenly infer that the risks of radiation-induced
neoplasms in general are necessarily negligible or
trivial.
Second, it is stated that improved radiotherapy
techniques over the past two decades deliver less
damage to surrounding tissues, and hence can be
assumed to be less carcinogenic. Although this is a
popular assumption, the well-recognized biphasic
relationship between radiation dose and tumour in-
duction cautions that it may not necessarily prove to
be correct.
3 Indeed, our own observations have sug-
gested that second tumours tend to cluster around
the ® eld edge, rather than within the most `dam-
aged’ region of irradiation (unpublished data).
Techniques to minimize beam scatter may therefore
remain relevant despite other modern technical
improvements.
4
Third, certain patient subsets may be at
signi® cantly higher risk of radiogenic second malig-
nancy than others, and hence less appropriately
reassured by the ® ndings of the review. In particu-
lar, we suggest that young patients ( , 35 years) fall
into this category
3,4 and advise that these patients
and their oncologists continue to include the hazard
of second malignancy in their therapeutic decision-
making algorithm.
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Sir: I wish to dispute the comments on my article by
Epstein et al. regarding the occurrence of second
tumours in the reduced dose regions at radiation
® eld edges. There is much evidence to the contrary,
from the development of breast cancers in mantle
ports of women treated for Hodgkin’s disease
1,2 to
the reports of sarcomas in regions of ® eld overlap.
3,4
In support of their hypothesis, Epstein et al. quote
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Karlsson et al. in their work,
3,4 but even including
cases of Stewart± Treves syndrome, 13 out of 17
cases of soft tissue sarcomas in this report
5 are inside
radiation ® elds, and integral dose was the most
signi® cant correlating factor. No evidence of an
increased risk for non-breast malignancies in the
vicinity of irradiated ® elds was reported in the analy-
sis of 1382 autopsies of breast cancer patients
treated at Roswell Park, where 86% of patients had
breast cancer as their only malignancy at the time of
death.
6
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